The dermatology drugs market includes medications that are used for the treatment of skin conditions such as dermatitis (including eczema), rosacea, hyperhidrosis, androgenic alopecia, onychomycosis, hair loss, acne, immune disorders (including psoriasis), microbial infections (bacterial, fungal, and viral), vascular and pigmented lesion removal, common warts, seborrheic keratosis, and other skin diseases.
The major reason why the global dermatology drugs market will increase from $33 billion in 2017 to close to $42 billion by 2021 is the increase in the number of indications treated by topical drugs
The USA was the largest country in the dermatology drugs market in 2017, accounting for nearly one-fourth of the market share. The factors attributed to the size of this market include high quality healthcare facilities, a high cost healthcare system and the GDP of the country. China and Japan followed the USA as the next largest countries in the market.
The dermatology drugs market is fragmented with a number of large and small drugs organizations. The top five competitors in the market made up around 45% of the total market in 2017. Johnson & Johnson was the largest competitor of the market, followed by Allergan Plc. and Galderma S.A. J&J was founded in 1886 and is headquartered in New Jersey, USA. The company is engaged in the development, manufacturing and marketing of personal care hygienic products, pharmaceuticals and surgical equipment.
About The Business Research Company.
The Business Research Company is a Business Intelligence Company which excels in company, market and consumer research. It has offices in the UK, the US and India and a network of trained researchers in 15 countries globally.
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: [email protected]